US20100319708A1 - Device for splinting a cavity, organ duct and/or vessel - Google Patents
Device for splinting a cavity, organ duct and/or vessel Download PDFInfo
- Publication number
- US20100319708A1 US20100319708A1 US12/096,457 US9645706A US2010319708A1 US 20100319708 A1 US20100319708 A1 US 20100319708A1 US 9645706 A US9645706 A US 9645706A US 2010319708 A1 US2010319708 A1 US 2010319708A1
- Authority
- US
- United States
- Prior art keywords
- stent
- phase
- tube
- phases
- length
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000000056 organ Anatomy 0.000 title claims abstract description 32
- 241001465754 Metazoa Species 0.000 claims abstract description 10
- 238000009954 braiding Methods 0.000 claims description 35
- 239000000835 fiber Substances 0.000 claims description 24
- 206010041235 Snoring Diseases 0.000 claims description 21
- 230000007704 transition Effects 0.000 claims description 15
- 239000002759 woven fabric Substances 0.000 claims description 15
- 201000002859 sleep apnea Diseases 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 8
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000012781 shape memory material Substances 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 5
- 239000003365 glass fiber Substances 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 3
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 238000003763 carbonization Methods 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 15
- 210000003800 pharynx Anatomy 0.000 description 9
- 208000008784 apnea Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 210000001584 soft palate Anatomy 0.000 description 4
- 238000003698 laser cutting Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 208000001797 obstructive sleep apnea Diseases 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000002409 epiglottis Anatomy 0.000 description 2
- 210000001983 hard palate Anatomy 0.000 description 2
- 201000000615 hard palate cancer Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000011301 standard therapy Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 206010013082 Discomfort Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000011513 continuous positive airway pressure therapy Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000005181 root of the tongue Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/56—Devices for preventing snoring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/56—Devices for preventing snoring
- A61F5/566—Intra-oral devices
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04C—BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
- D04C1/00—Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
- D04C1/06—Braid or lace serving particular purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/18—Internal ear or nose parts, e.g. ear-drums
- A61F2/186—Nose parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/20—Epiglottis; Larynxes; Tracheae combined with larynxes or for use therewith
- A61F2/203—Epiglottis; Larynxes; Tracheae combined with larynxes or for use therewith comprising an air passage from trachea to oesophagus or to pharynx; Artificial epiglottis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0048—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/06—Vascular grafts; stents
Abstract
The invention relates to a device for splinting and/or maintaining a cavity, an organ duct and/or a vessel in a human or animal body, said device comprising at least one compressible and self-expanding stent that is composed of at least three phases.
Description
- The present invention relates to a device for the splinting and/or holding open of a cavity, an organ duct and/or a vessel in the human or animal body with at least one compressible and self-expanding stent which has at least one expanded phase.
- Syndromes based on the at least partial closure of cavities, organ ducts and/or vessels are increasing sharply due to the effects of civilisation. An important area of such syndromes relates to the air passages. For example obstructive sleep apnea is a life-threatening illness resulting from the closure of the rear air passages due to muscle relaxation during sleep. Through repeated and sometimes very frequent interruption of breathing during sleep, the patient is not adequately supplied with oxygen, in extreme cases leading to death. Civilisation-related factors such as e.g. severe obesity or excessive alcohol consumption seriously increase the risk of illness. Snoring is a gentler outcome of the effect than sleep apnea, but results from the same organic cause. Whereas people are aware of snoring, the serious risks to health especially of heavy snoring and of sleep apnea are often not registered, since the patient is not aware of the organic deficiency symptoms.
-
FIG. 1 shows free airways through which normal breathing takes place. The relaxation of the tongue and of the surrounding muscles in the pharyngeal cavity which occurs during sleep leads, due to the inflowing air, to vibrations of the soft palate and the soft parts of the throat, resulting in the noise of snoring. Strong relaxation of the throat tissue and the falling back of the root of the tongue may lead to complete closure of the air passages (FIG. 2 ). After a certain time (approx. 60-90 seconds) the brain generates a waking reaction. The transition from snoring to apnea is fleeting. The interruption of breathing may last up to 1.5 minutes and be repeated 200-400 times during the night, which does not allow the patient any deep sleep. The consequences are restless sleep, tiredness during the day, high blood pressure, lack of drive, etc. If the illness is not treated, then the body is unable to regenerate adequately in sleep, leading to a lower expectation of life. Increased fluctuations of pressure within the thorax may in certain circumstances have adverse effects on the cardiovascular system. Consequences of snoring are high blood pressure and a drop in the oxygen content of the blood. It is nowadays assumed that in particular during sleep apnea, but also during snoring, significant organic consequent illnesses may occur. - The Health Technology Assessment Report, volume 25 “The Sleep Apnea Syndrome” by Perleth et al., Asgard Verlag St. Augustin 2003, establishes on the basis of epidemiological studies a prevalence of sleep apnea among around 2-4% of the population of Germany, i.e. roughly 2 to 3 million affected persons. In diagnostic tests conducted in sleep laboratories, accordingly, around half of all patients turned out to be affected by apnea and urgently in need of treatment. Other sources assume a proportion of only 5% for diagnosed illness treated by therapy. According to Prof. Dr. Frank Michael Baer of the University Clinic, Cologne, a third of the male population of Germany are regular snorers. Snoring requires treatment for 4% of men and 2% of women aged between 30 and 60 years. At the same time, the incidence of snoring rises sharply with age. Thus, while only about 10% of the population snore at the age of 20, this rises to around 50% at the age of 50. In short, sleep apnea is an illness of socially relevant character with increasing prevalence and importance, in which only a small portion of those affected are known and receiving treatment. There is therefore also a need for new, simple, but effective options for therapy.
- The current standard therapy for sleep apnea is the active supply to the patient of respiratory air under overpressure by means of an n-CPAP breathing apparatus (nasal continuous positive airway pressure). Through the night-time wearing of a breathing mask, through which a continuous positive airway pressure is generated, the air passages are held sufficiently open. The principle of operation is illustrated in
FIG. 3 . Significant drawbacks to this standard therapy, which is to date the sole treatment option with medical effectiveness, are the discomforts to the patient, created above all by the wearing of an airtight oxygen mask for the whole night, fixed via an adequately strong headband and connected via the supply tube to the breathing apparatus; also through drying out of the mucous membranes and the need for moistening of the respiratory air, plus the operating noise of the breathing apparatus. In addition to the severely restricted freedom of movement during sleep, there is the risk of air escaping due to leaks between the breathing mask and the skin of the face, so that the overpressure is accidentally reduced and may no longer be sufficient. Moreover, acceptance of the nightly wearing of a breathing mask is very limited in time for many patients, even though life-long therapy is required. The HTA report referred to above reported that the acceptance of CPAP treatment, in particular long-tem, is relatively low. Less than half of patients to whom CPAP was recommended carried out the treatment long-term (i.e. for more than one month). It was notable that, despite proof of significant therapeutic effectiveness only for the CPAP mask, there was a clear but subjective preference by patients for an intraoral splint, probably due to the lower subjective stress of this therapy. The intraoral splint is claimed to provide at least partial improvement of symptoms by ensuring breathing through the mouth. A further drawback of the CPAP mask is the need to take the breathing apparatus with one when travelling. There is also the time and effort required for cleaning and maintenance. - On account of these severe stresses and restrictions for the patient, apnea patients suffer a high degree of mental trauma and have great interest in alternative and subjectively more tolerable therapy options. The prevailing view is that as yet no efficient alternative treatment option has been developed which may be used routinely, and is also practicable and cost-effective.
- A large number of proposals have been made for the physical prevention of snoring and apnea, but none have become established on the market. Described in DE 195 01 363 is a device for insertion through the mouth, characterised by a tube which may be introduced into and fixed in the pharynx. It is meant to prevent the collapse of the soft parts of the pharynx. A drawback cited by the inventor is the need to overcome nausea. Experience shows that the route described here, via the mouth, is impracticable, and does not lead to adequate reduction of symptoms. A similar device to support the soft palate parts in the nose and throat area, but which is intended for introduction through the nose, is proposed in DE 100 28 013. The effect is just as limited as the instrument described above. Alternatively, in WO 98/23233 it is proposed to introduce a double tube through the nose to maintain the air supply passage, but this is just as ineffective as the two instruments described above. DE 102 40 725 describes a probe against apnea and snoring, which is expandable at the end by means of a drawing element. It is not described how in practice the expansion by means of the drawing element takes place or how the expanded probe is stabilised in the air passage.
- The present invention is now based on the problem on the one hand of avoiding the aforementioned drawbacks of the prior art, and on the other hand of making possible a practicable splinting and/or holding open of cavities, organ ducts and/or vessels in the human or animal body. Here, for the treatment of illnesses such as snoring and apnea, repeated daily use of a device according to the invention is necessary, and therefore special requirements are placed on the durability of any such medical instrument. At the same time the principle according to the invention for the device should be effective not only specifically in the air passages for the treatment of snoring and/or sleep apnea, but should also be capable of application for the splinting and/or holding open of other cavities, organ ducts and/or vessels in the human or animal body.
- The problem is solved by a device for the splinting and/or holding open of cavities, organ ducts and/or vessels in the human or animal body with at least one self-expanding stent which is compressible in a tube and develops at least two phases, characterised in that at least one phase of the stent has a greater expansion, i.e. a greater diameter in the expanded state. In a preferred embodiment, the distal end of the at least one stent is expanded. The problem is further solved by providing that the at least one stent in a further preferred embodiment may be made to have at least three phases, and the different phases of the at least one stent may have different degrees of expansion, wherein the at least one transition phase so connects the at least two functional phases with one another that the latter may assume their configuration unaffected by one another. In an even more preferred embodiment, the at least one transition phase is formed by the twining around of at least two wires, fibres and/or threads (“twist”). Developments of the invention are defined in the relevant dependent claims.
- In this way a device is created which, in the compressed state, is inserted in the cavity, organ duct and/or vessel after which, by drawing back an outer tube, the inner at least one stent is released, self-expands and, at least with the phase of greatest expansion, fits up against the wall of the cavity, organ duct and/or vessel. By pushing the tube back over the expanded stent, the device may be compressed again and easily removed from the cavity, organ duct and/or vessel. By means of the expanded stent, the cavity, organ duct and/or vessel is splinted and/or held open. The tube containing the compressed stent is so dimensioned that it may easily be inserted into the cavity, organ duct and/or vessel, even when the cavity, organ duct and/or vessel is in a collapsed state. Preferably the stent is made of a shape memory material. In the operating state, the device is expanded only over a small part in one phase of the stent, again preferably at the distal end, while the other part at the other end of the stent undergoes only a fairly limited expansion on release from the tube. The size and length relationships of the phases of the at least one stent relative to one another may be freely selected.
- Due to the elastic construction of the stent and the elasticity of the surrounding tube, the device may easily follow any curvature of the cavity, organ duct and/or vessel. Optimal adaptation of the stent to the anatomy of the cavity, organ duct and/or vessel is possible with very great ease, due to the scope for varying the elastic expansion of the stent.
- Preferably the stent has a net structure and/or a multiplicity of openings with different angles of opening and/or opening widths in the phases. It is especially preferred for the stent to be made of braiding and/or woven fabric and/or interlaid scrim, in particular from a wire, thread and/or fibre braiding or woven fabric or interlaid scrim. In another embodiment, the at least one stent may be made from a tube slit over at least part of its length, and produced in an especially preferred manner e.g. by laser cutting of a metal or nitinol tube.
- Through the expanded phase with the greater diameter of the at least one stent, a reliable and defined expansion for the splinting and/or holding open of the cavity, organ duct and/or vessel only in a specific, pre-defined area of the stent is ensured. In the at least one proximal phase, the stent has preferably smaller angles of opening in its longitudinal direction, and in the at least one distal phase the stent has preferably larger angles of opening in its longitudinal direction, so that the necessary force for expansion, splinting and/or holding open of the cavity, organ duct and/or vessel in this area can be obtained. In another preferred embodiment, the angles of opening in the longitudinal direction of the stent may be larger in the at least one proximal phase and smaller in the at least one distal phase. In a preferred embodiment with at least three phases, in order to create a transition zone between two functional phases of the stent in the at least one transition phase, the stent is comprised preferably of openings which are larger than those in the functional phases, so that after release from the tube they may adopt their configuration uninfluenced by one another. In an especially preferred version this is obtained by a twisting of at least two wires, fibres and/or threads. In another preferred embodiment these openings may be made by laser cutting in a metal or nitinol tube.
- The material of the at least one stent may be provided with a coating, in particular with a bio-compatible surface coating, heparin, a carbonisation of nitinol, a nano-technological coating, x-ray-proof particles, a coating releasing an active substance, a preferably microporous bio-technological, or another other coating. Through the provision of such a coating, in addition to the physical effect, a pharmaceutical effect for example may also be provided. Moreover, by providing a coating which roughens the surface of the stent, fixing of the stent at the point of action is improved. In this connection, though, care is preferably taken to avoid any damage to the respective wall of the cavity, organ duct and/or vessel in the human or animal body in which the stent is used.
- Preferably the at least one stent is/are made of a bio-compatible shape memory material, in particular a metal or a metal alloy, in particular a stainless steel or nitinol or another bio-compatible material, such as in particular a plastic, or monofile and/or multifile and/or composite glass fibres. Since the stent remains for at least several hours up to days in the human body, it is especially advantageous to use a bio-compatible material to avoid rejection effects and allergic reactions. To impress upon the stent the expanded form, with subsequent compression, and to allow it to open through self-expansion, a shape memory material is advantageously chosen.
- In an even more preferred embodiment, the stent has at the distal end round ends, i.e. the wire or fibre or thread is guided back into the braiding or woven fabric or interlaid scrim, so that there are no open wire or fibre or thread ends at the distal end of the stent, which could lead to damage to the relevant wall of the cavity, organ duct and/or vessel. In an even more preferred embodiment, the round ends at the distal end are bent slightly inwards.
- In a preferred embodiment the proximal end of the stent is fixed by at least one end of the wire or fibre or thread, which is open by virtue of its construction, in a closure, e.g. bonded. In the same way, connection may also be made to a pulling element, with the aid of which the stent together with the tube may be inserted in and removed from the cavity, organ duct and/or vessel. In an even more preferred embodiment, this closure is a threaded closure.
- To protect the stent from slipping into the cavity, organ duct and/or vessel, the stent may be provided at the proximal end with a fastening, which in a preferred embodiment may be adjusted variably to the anatomical features concerned in each case. The tube may be longer, the same length or shorter than the stent, and where necessary extended by an additional piece needed for handling, downwards from the stent, e.g. beyond the pulling element, and with which it may be adapted flexibly to the particular conditions of use. In a preferred manner of use, the device may be pushed forward directly up to the point of use and there released by withdrawing the tube from the stent. This may involve partial or complete withdrawal of the tube. In another preferred embodiment, the device may be pushed forward until just before the point of use only, and then the stent pushed out of the tube forward to the point of use, after which the tube is withdrawn wholly or partly or is even not withdrawn at all.
- For the treatment of snoring and/or apnea the device is preferably so dimensioned that the distal end of the at least one stent just reaches the epiglottis, to avoid irritation of the pharynx and nausea. Here the distal expanded phase of the stent preferably has a length of 0.5 cm to 20 cm. The whole stent preferably has a length of 2 cm to 50 cm. The length of the tube is preferably between 0.5 cm and 50 cm. In a most preferred embodiment, the whole stent has a length of 10 cm to 35 cm with a distal expanded phase between 1 cm and 10 cm in length, and with a 10 cm to 35 cm long tube. It has been shown that, with such a device in the dimensions described and for human use, the air passages may be reliably and reproducibly held open during sleep, and the oxygen saturation in the blood for an apnea patient is able to rise above the critical limit value of 90%. Consequently, replacement of the n-CPAP breathing mask by the device according to the invention for the splinting and/or holding open of a cavity, organ duct and/or vessel is possible easily, efficiently and with very good physical tolerance by the patient.
- In a similar manner to the treatment of snoring and/or sleep apnea, it is possible to use the device according to the invention for the treatment of bronchial stenosis, bile duct constrictions and for the splinting and/or holding open of blood vessels, lymph vessels, urinary ducts, Fallopian tubes and sections of bowel. This list is not intended to be limiting for the range of application of a device according to the invention, but is rather meant to illustrate the breadth of scope for such application.
- For a more detailed explanation of the invention, embodiments will be described in detail below with the aid of the drawings, which show in:
-
FIG. 1 the free air passage during sleep, -
FIG. 2 the blocked air passage during sleep as the cause of snoring and obstructive sleep apnea, and -
FIG. 3 the opening of the air passages by n-CPAP therapy. -
FIG. 4 shows a view of the components of a first embodiment of a device according to the invention for the splinting and/or holding open of a cavity, organ duct and/or vessel with a three-phase stent. -
FIG. 5 shows a view of a three-phase stent of a first embodiment of a device according to the invention. -
FIG. 6 shows a braiding pattern with round ends at the distal end of the braiding and/or woven fabric and/or interlaid scrim of a stent of a second embodiment of a device according to the invention, in which only one wire or fibre or thread is always guided back separately and directly. -
FIG. 7 shows a braiding pattern with round ends at the distal end of the braiding and/or woven fabric and/or interlaid scrim of a stent of a third embodiment of a device according to the invention, in which two wires or fibres or threads always cross at the return point. -
FIG. 8 shows a braiding pattern with round ends at the distal end of the braiding and/or woven fabric and/or interlaid scrim of a stent of a third embodiment of a device according to the invention, in which at least two wires or fibres or threads are guided back at least partly parallel. -
FIG. 1 shows the nasal chamber (1), the hard palate (2), the trachea (3), the soft palate (4), the oral cavity (5), the free airways (6) and the tongue (7). Illustrated is the free airway during sleep of a healthy person.FIG. 2 shows the closed airway (8) in the pharynx, as occurs in obstructive sleep apnea.FIG. 3 shows the use of the n-CPAP breathing apparatus with the breathing mask (9) in place, and the air passages opened by the overpressure. -
FIG. 4 shows a view of the components of a first embodiment of a device according to the invention for the splinting and/or holding open of a cavity, organ duct and/or vessel in a human or animal body. The device comprises a three-phase stent (10), connected at its proximal end (21) via a connecting element (11) to the connecting element (12) of a pulling element (13). To insert the stent into the cavity, organ duct and/or vessel, the stent is inserted into the tube (14) and compressed. At its proximal end (21), the stent (10) is firmly fixed in a connecting element (11). By this means, in the possible presence for design reasons of an open wire or fibre or thread end at the proximal end (21) of the stent (10), its cohesion is simultaneously ensured. Also created via the connecting element (11), which may contain e.g. a screw thread, is the connection to the connecting element (12) of the pulling element (13), which may similarly contain a screw thread. The tube (14) may be made preferably of a plastic polymer, for example a PTFE, PVC, PE, PU, silicon or Teflon tube, or be a catheter. The puling element (13) may be made preferably of a plastic, a metal or a metal alloy, or glass fibre materials. In another embodiment, the two connecting elements (11) and (12) may be produced as a single solid element, so that the stent (10) is permanently connected to the pulling element (13). - For the use of a device according to the invention for the treatment of snoring and/or sleep apnea, the device is inserted, compressed in the tube (14), into one of the two nostrils and preferably pushed forward as far as possible towards the epiglottis, and positioned at its point of use. By withdrawing the tube (14), the stent (10) is released, and self-expands to its pre-impressed size. This prevents the collapse of the pharynx and the closing of the air passages. A free airflow and normal breathing are thereby made possible. In a further embodiment, to set the depth of insertion and to prevent the stent from accidentally slipping into the air passage, a fastening (15) may be fixed at the proximal end (21) of the stent (10). A mounting plate (16) may also be provided to prevent the stent from accidentally slipping into the air passage and the pharynx. After insertion of the device and release of the stent (10) by withdrawing the tube (14), the pulling element (13) is separated and removed from the stent (10) by releasing the connecting element (12) from the connecting element (11). In this phase and fixed by the fastening (15) and if applicable the mounting plate (16), the stent is worn during sleep. In a further embodiment, an additional fastening of the stent to the head may be provided as security against it slipping out of the air passage. This may be provided for example by a soft headband, which may be fastened to the mounting plate.
-
FIG. 5 shows a view of a three-phase stent (10) in a first embodiment of a device according to the invention for the splinting and/or holding open of a cavity, organ duct and/or vessel in a human or animal body for the treatment of snoring and/or sleep apnea. The distal functional phase (17) of the stent is in this first embodiment the therapeutically active part of the medical device, which is expanded sufficiently to hold open the air passages. The proximal functional phase (19) of the stent may be used in particular for locating the stent in the nasal area and is accordingly expanded only slightly. The distal phase (17) therefore has a greater expansion diameter than the proximal phase (19). To ensure reliably the differing expansion of the distal phase (17) and the proximal phase (19) of the stent (10), and also to achieve this for many times repeated use of the device, involving on each occasion an opening and a closing process, the distal phase (17) and the proximal phase (19) are connected to one another by a transition phase (18), preferably twisted together and which, through the stability of the twisted wires, fibre or threads allows the distal phases to assume their configuration, uninfluenced by one another, after release from the tube. The design of the stent (10), in this form of at least three phases, composed of at least two functional phases and at least one transition phase is an important element of an embodiment of a device according to the invention and thus distinguishes the stent (10) significantly from the nowadays generally common stents for the canalisation or holding open of e.g. blood vessels. - In principle, the phase with the greatest diameter in the expanded state of the at least three phases of the at least one stent (10) may be chosen freely. Here a transition phase (18) may have either the same or a greater or even a smaller diameter than the functional phases. The transition phase (18) is preferably created by the twisting of at least two wires or fibres or threads, while the other phases are preferably constructed through the crossing of at least one thread. For the construction of the less expanded phase, preferably a braiding and/or woven fabric and/or interlaid scrim with smaller angles of opening in the longitudinal direction of the stent is chosen. For the construction of the more expanded phase, preferably a braiding and/or woven fabric and/or interlaid scrim with larger angles of opening in the longitudinal direction of the stent is chosen.
- To obtain especially good stability of the stent combined simultaneously with optimal air permeability, the stent has a net structure. This may be formed e.g. by a wire, thread and/or fibre braiding and/or woven fabric and/or interlaid scrim. Alternatively a cut tube may be provided with such a structure, with openings of different sizes, especially preferably prepared by laser cutting of a metal or nitinol tube. The important factor here is a number of openings sufficient to allow an unimpeded air flow. The stent may therefore have a very fine network or a coarser network. In a preferred embodiment, the stent is made from a shape memory material. This may be for example nitinol, stainless steel, plastic or monofile, multifile and/or composite glass fibre material. In a preferred embodiment, the stent is made by manual or machine braiding in predefined patterns to produce the different phases.
- A particular problem with repeated insertion and removal of a device according to the invention on the one hand, and possible use in open cavities on the other hand lies in the fact that open ends of a material from which the braiding and/or woven fabric and/or interlaid scrim of the stent (10) is made may lead to irritation of the wall of the cavity, organ duct and/or vessel. To avoid this problem, it is preferable for the stent (10) to have closed ends, at least at the distal end (20) of the stent. Closed ends, especially in braided systems, are at present not generally to be found in commercially available stents. Instead, these are usually open at both ends. For the device according to the invention, therefore, special new braiding patterns have been developed and stents according to the invention produced. Here the stent (10) may be made preferably of only one wire or one fibre or one thread, to give only closed ends at the distal end (20) of the stent (10), and two open wire or fibre or thread ends at the proximal end (21) of the stent (10). In another preferred embodiment, the number of wires or fibres or threads used to produce the stent (10) matches the number of closed ends required. This may be for example 12, 18 or 24 wires or fibres or threads for 12, 18 or 24 closed ends at the distal end (20) of the stent (10). This results in 24, 36 or 48 open wire or fibre or thread ends at the proximal end (21) of the stent (10). Since the proximal end (21) of the stent (10) is fixed firmly in the connecting element (11), all open ends of the wires or fibres or threads at the proximal end (21) of the stent (10) are in any case firmly tied in and represent no danger to the patient.
- In choosing the strength of the wire or fibre or thread, the material properties should be balanced with the mechanical properties of the braiding and/or woven fabric and/or interlaid scrim. In a preferred embodiment, the stent (10) is made of nitinol wire with a diameter of 0.001 mm to 2 mm, even more preferably with a diameter of 0.05 mm to 0.5 mm, and most preferably with a diameter of 0.1 mm to 0.2 mm. The diameter of the nitinol wire, and the density and angle of opening of the braiding determine the forces involved in the expansion and holding open of the cavity, organ duct and/or vessel in the more strongly expanded phase of the stent (10). In certain forms of treatment such as that for snoring and sleep apnea, these forces contribute significantly to the well-being of the patient.
-
FIG. 6 shows a braiding pattern with round ends at the distal end (20) of the stent (10) in a preferred embodiment of a device according to the invention, in which in each case only one wire or fibre or thread is guided back separately into the braiding. In a preferred embodiment, the incoming wire or fibre or thread is guided back round directly into the braiding. In another preferred embodiment (FIG. 7 ), the incoming wire or fibre or thread is so guided back that two wires or fibres or threads always cross at the return point. These embodiments are not intended to be limiting for possible braiding patterns for the return of one incoming wire or fibre or thread. Instead, many other suitable embodiments are possible amongst those described above and shown inFIGS. 6 and 7 , in order to obtain round ends at the distal end (20) of the stent (10) in a braiding, with in each case only one single wire or fibre or thread being guided back. These other suitable embodiments are included here. -
FIG. 8 shows a braiding pattern with round ends at the distal end (20) of the stent (10) in a preferred embodiment of a device according to the invention, in which at least two wires or fibres or threads are guided back at least partly parallel. In a preferred embodiment, the incoming wire or fibre or thread is guided back round into the second position within the braiding pattern. In another preferred embodiment, the incoming wire or fibre or thread is guided back round into the third or subsequent position within the braiding pattern. These embodiments are not intended to be limiting for possible braiding patterns for the return of an incoming wire or fibre or thread. Instead, many other suitable embodiments are possible amongst those described above and shown inFIG. 8 , in order to obtain round ends at the distal end (20) of the stent (10) in a braiding, wherein at least two wires or fibres or threads are guided back at least partly parallel. These other suitable embodiments are included here. The advantage of the braiding pattern depicted inFIGS. 7 and 8 and of similar braiding patterns is that, on the one hand, the distal end (20) of the stent (10) is given greater stability, and on the other hand greater rounding may be obtained than in the braiding patterns depicted inFIG. 6 and similar braiding patterns. This latter feature contributes to comfort in use for the patient. - In connection with the embodiments described above and shown in the figures of a device for the splinting and/or holding open of a cavity, organ duct and/or vessel in the human or animal body, it is possible for numerous further embodiments to be created. In particular the shape of the stent may be matched to the shape of the cavity or organ duct or vessel. In some cases shorter stents with a larger opening diameter are more suitable, while at other points of use narrower, longer stents may be advantageous. In the case of the embodiments described above and shown in the figures of a stent with at least three phases, numerous further embodiments may similarly be created. In each of these embodiments, at least one functional phase of the stent is connected to at least one other functional phase by a transition phase which facilitates the free development of the two different configurations of the functional phases.
-
- 1 nasal chamber
- 2 hard palate
- 3 trachea
- 4 soft palate
- 5 oral cavity
- 6 free airways
- 7 tongue
- 8 closed airways
- 9 nose mask of the n-CPAP apparatus
- 10 stent
- 11 connecting element
- 12 connecting element
- 13 pulling element
- 14 tube
- 15 fastening
- 16 mounting plate
- 17 distal functional phase of the stent
- 18 transition phase of the stent
- 19 proximal functional phase of the stent
- 20 distal end of the stent
- 21 proximal end of the stent
Claims (30)
1. A device for the splinting and/or holding open of a cavity, organ duct and/or vessel in the human or animal body, the device comprising at least one stent which is compressible in a tube and is self-expanding, wherein the stent comprises at least three phases, wherein at least two of these phases are functional phases and at least one of these phases is a transition phase.
2. The device according to claim 1 , wherein the two or more functional phases have different degrees of expansion and wherein the cavity, organ duct and/or vessel is splinted and/or held open by those functional phases of the stent with the greater degree of expansion.
3. The device according to claim 2 , wherein the stent has a distal phase and a proximal phase and the the distal phase of the stent has a greater degree of expansion than the proximal phase.
4. The device according to claim 3 , wherein the distal phase of the stent has a length of 0.5 cm to 20 cm, the tube a length of 0.5 cm to 50 cm and the whole stent a length of 2 cm to 50 cm.
5.-9. (canceled)
10. The device according to claim 3 , wherein the distal phase has a smaller degree of expansion than the proximal phase of the stent.
11. The device according to claim 3 , wherein the stent has a net structure and/or a multiplicity of openings, wherein the openings of the transition phase are larger than those of the functional phases.
12. The device according to claim 3 , wherein the functional phases (17, 19) and/or the transition phases are made of at least one braiding and/or woven fabric and/or interlaid scrim.
13. The device according to claim 12 , wherein the transition phase in each case at least two wires, fibres or threads are twisted together.
14. The device according to claim 13 , wherein the wire, fibre or thread for the production of the stent has a diameter of preferably 0.001 mm to 2 mm.
15. The device according to claim 13 , wherein the wire, fibre or thread for the production of the stent has a diameter of preferably 0.05 mm to 0.5 mm.
16. The device according to claim 13 , wherein the wire, fibre or thread for the production of the stent has a diameter of preferably 0.1 mm to 0.2 mm.
17. The device according to claim 3 , wherein the tube is slotted over at least part of the length of the stent.
18. The device according to claim 1 , wherein the stent is made of a shape memory material.
19. The device according to claim 3 , wherein the stent is made of a bio-compatible shape memory material, comprising a metal, metal alloy, stainless steel, nitinol, plastic, monofile, multifile or composite glass fibres.
20. The device according to claim 3 , wherein the proximal phase comprises an end that has exclusively closed ends.
21. The device according to claim 3 , wherein Stent at least one open end at the proximal end is firmly fixed in a closing element.
22. The device according to claim 3 , wherein the distal end has 12, 18 or 24 closed ends.
23.-24. (canceled)
25. The device according to claim 1 , wherein the stent is further provides a coating selected from the group consisting of a bio-compatible surface coating, heparin, a carbonisation of nitinol, a nano-technological coating, x-ray-proof particles, a coating releasing an active substance, anr a microporous bio-technological coating.
26. (canceled)
27. A method of producing a compressible, self-expanding braiding and/or woven fabric and/or interlaid scrim with round ends in the longitudinal direction, wherein in that in each case only one wire or one fibre or one thread is guided back directly round into the braiding and/or woven fabric and/or interlaid scrim or in such a way that two wires or fibres or threads always cross at the return point.
28. (canceled)
29. Method of producing a compressible, self-expanding braiding and/or woven fabric and/or interlaid scrim with round ends in the longitudinal direction, characterised in that at least two wires or fibres or threads are guided back at least partly parallel.
30.-31. (canceled)
32. A method for the treatment of snoring and/or sleep apnea, the method comprising inserting the stent of claim 3 into the nose up to the point of use, the tube is withdrawn from the nose to release the stent from the tube, and the stent expands and fits up against the inner walls of the air passages, at least in the area of the distal end.
33.-36. (canceled)
37. The method according to claim 32 , wherein the at least two functional phases have different degrees of expansion and wherein the air passages are splinted and/or held open by the distal functional phase of the stent with the greater degree of expansion.
38. The device according to claim 1 , wherein the distal phase (17) of the stent (10) has a length of 0.5 cm to 20 cm, the tube (14) a length of 0.5 cm to 50 cm and the whole stent (10) a length of 2 cm to 50 cm.
39. The device according to claim 1 , wherein the distal phase (17) of the stent (10) has a length of 1 cm to 10 cm, the tube (14) a length of 10 cm to 35 cm and the whole stent (10) a length of 10 cm to 35 cm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/632,596 US10492932B2 (en) | 2005-12-06 | 2012-10-01 | Device for splinting a cavity, organ duct and/or vessel |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005058242.7 | 2005-12-06 | ||
DE102005058242A DE102005058242B3 (en) | 2005-12-06 | 2005-12-06 | Snoring prevention insert has outer tube for guiding mesh into nasal air passage to reduce closure |
DE102006040301.0 | 2006-08-29 | ||
DE102006040301A DE102006040301A1 (en) | 2005-12-06 | 2006-08-29 | Device for splinting a cavity, organ path and / or vessel |
DEPCT/DE2006/012137 | 2006-12-01 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2006/002137 A-371-Of-International WO2007065408A2 (en) | 2005-12-06 | 2006-12-01 | Device for splinting a cavity, organ duct and/or vessel |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/632,596 Continuation-In-Part US10492932B2 (en) | 2005-12-06 | 2012-10-01 | Device for splinting a cavity, organ duct and/or vessel |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100319708A1 true US20100319708A1 (en) | 2010-12-23 |
Family
ID=37907009
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/096,457 Abandoned US20100319708A1 (en) | 2005-12-06 | 2006-12-01 | Device for splinting a cavity, organ duct and/or vessel |
US13/632,596 Active US10492932B2 (en) | 2005-12-06 | 2012-10-01 | Device for splinting a cavity, organ duct and/or vessel |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/632,596 Active US10492932B2 (en) | 2005-12-06 | 2012-10-01 | Device for splinting a cavity, organ duct and/or vessel |
Country Status (6)
Country | Link |
---|---|
US (2) | US20100319708A1 (en) |
EP (1) | EP1959882B1 (en) |
JP (1) | JP2009518082A (en) |
CA (1) | CA2632420C (en) |
DE (1) | DE102006040301A1 (en) |
WO (1) | WO2007065408A2 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110178439A1 (en) * | 2008-10-02 | 2011-07-21 | Irwin John N | A palate retainer with attached nasopharyngeal airway extender for use in the treatment of obstructive sleep apnea |
WO2012066464A2 (en) * | 2010-11-15 | 2012-05-24 | Sody Naimer | Oropharyngeal airway support assembly |
US20130023919A1 (en) * | 2004-11-19 | 2013-01-24 | Pulmonx, Inc. | Implant loading device and system |
US20140018839A1 (en) * | 2011-02-09 | 2014-01-16 | Peter Renner | Stent for splinting a nasal passage |
US8998986B1 (en) | 2013-07-05 | 2015-04-07 | Zdzislaw B. Malinowski | Nasal stent |
CN106163457A (en) * | 2014-03-13 | 2016-11-23 | 克劳斯·迪林 | Boards wall and/or stay open the compressible from expanding cribbing of the chamber in human body or animal body, organ conduit and/or blood vessel |
US20180055666A1 (en) * | 2015-09-30 | 2018-03-01 | Neurvana Medical, Llc | Treatment Systems Processes and Devices Addressing Cerebral Vasospasm/Vasoconstriction |
WO2020001627A1 (en) * | 2018-06-29 | 2020-01-02 | 小牛科技河北有限公司 | Nasopharynx stent for stopping snoring |
WO2020001618A1 (en) * | 2018-06-29 | 2020-01-02 | 小牛科技河北有限公司 | Nasopharynx stent for stopping snoring |
US10569037B2 (en) | 2014-02-14 | 2020-02-25 | John M. O'Day | Nasopharyngeal device for obstructive sleep apnea syndrome |
US11510806B2 (en) | 2008-11-25 | 2022-11-29 | Lumen Devices, Llc. | Devices, systems and methods for the treatment of sleep apnea |
US11517471B2 (en) | 2011-02-17 | 2022-12-06 | Lumen Devices, Llc. | Apparatus and methods for the treatment of sleep apnea |
US20220401253A1 (en) * | 2021-06-18 | 2022-12-22 | Diego Gonzalez Joven | Device for preventing sleep apnea and snoring |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10336902C5 (en) | 2003-08-08 | 2019-04-25 | Abiomed Europe Gmbh | Intracardiac pumping device |
US8118836B2 (en) | 2004-11-05 | 2012-02-21 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US7749250B2 (en) | 2006-02-03 | 2010-07-06 | Biomet Sports Medicine, Llc | Soft tissue repair assembly and associated method |
US7905904B2 (en) | 2006-02-03 | 2011-03-15 | Biomet Sports Medicine, Llc | Soft tissue repair device and associated methods |
US8298262B2 (en) | 2006-02-03 | 2012-10-30 | Biomet Sports Medicine, Llc | Method for tissue fixation |
US9017381B2 (en) | 2007-04-10 | 2015-04-28 | Biomet Sports Medicine, Llc | Adjustable knotless loops |
US8088130B2 (en) | 2006-02-03 | 2012-01-03 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US8361113B2 (en) | 2006-02-03 | 2013-01-29 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US7909851B2 (en) | 2006-02-03 | 2011-03-22 | Biomet Sports Medicine, Llc | Soft tissue repair device and associated methods |
US8303604B2 (en) | 2004-11-05 | 2012-11-06 | Biomet Sports Medicine, Llc | Soft tissue repair device and method |
US7658751B2 (en) | 2006-09-29 | 2010-02-09 | Biomet Sports Medicine, Llc | Method for implanting soft tissue |
US8128658B2 (en) | 2004-11-05 | 2012-03-06 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to bone |
US8137382B2 (en) | 2004-11-05 | 2012-03-20 | Biomet Sports Medicine, Llc | Method and apparatus for coupling anatomical features |
US11259792B2 (en) | 2006-02-03 | 2022-03-01 | Biomet Sports Medicine, Llc | Method and apparatus for coupling anatomical features |
US10517587B2 (en) | 2006-02-03 | 2019-12-31 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US9468433B2 (en) | 2006-02-03 | 2016-10-18 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US8968364B2 (en) | 2006-02-03 | 2015-03-03 | Biomet Sports Medicine, Llc | Method and apparatus for fixation of an ACL graft |
US8801783B2 (en) * | 2006-09-29 | 2014-08-12 | Biomet Sports Medicine, Llc | Prosthetic ligament system for knee joint |
US8597327B2 (en) | 2006-02-03 | 2013-12-03 | Biomet Manufacturing, Llc | Method and apparatus for sternal closure |
US8562645B2 (en) | 2006-09-29 | 2013-10-22 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US11311287B2 (en) | 2006-02-03 | 2022-04-26 | Biomet Sports Medicine, Llc | Method for tissue fixation |
US9078644B2 (en) | 2006-09-29 | 2015-07-14 | Biomet Sports Medicine, Llc | Fracture fixation device |
US8562647B2 (en) | 2006-09-29 | 2013-10-22 | Biomet Sports Medicine, Llc | Method and apparatus for securing soft tissue to bone |
US8652171B2 (en) | 2006-02-03 | 2014-02-18 | Biomet Sports Medicine, Llc | Method and apparatus for soft tissue fixation |
US11259794B2 (en) | 2006-09-29 | 2022-03-01 | Biomet Sports Medicine, Llc | Method for implanting soft tissue |
US8672969B2 (en) | 2006-09-29 | 2014-03-18 | Biomet Sports Medicine, Llc | Fracture fixation device |
US8439859B2 (en) | 2007-10-08 | 2013-05-14 | Ais Gmbh Aachen Innovative Solutions | Catheter device |
US8489190B2 (en) | 2007-10-08 | 2013-07-16 | Ais Gmbh Aachen Innovative Solutions | Catheter device |
EP2194278A1 (en) | 2008-12-05 | 2010-06-09 | ECP Entwicklungsgesellschaft mbH | Fluid pump with a rotor |
JP2010159998A (en) * | 2009-01-06 | 2010-07-22 | Mitsubishi Electric Corp | Isar test equipment |
US8151682B2 (en) | 2009-01-26 | 2012-04-10 | Boston Scientific Scimed, Inc. | Atraumatic stent and method and apparatus for making the same |
JP3151095U (en) * | 2009-02-03 | 2009-06-11 | 有限会社Ur企画 | Nasal airway with side holes |
DE202009010388U1 (en) | 2009-07-31 | 2010-12-09 | Düring, Klaus, Dr. | Fixation device for fixing an apnea stent in the airway |
EP2388029A1 (en) | 2010-05-17 | 2011-11-23 | ECP Entwicklungsgesellschaft mbH | Pump array |
EP2399639A1 (en) | 2010-06-25 | 2011-12-28 | ECP Entwicklungsgesellschaft mbH | System for introducing a pump |
EP2407186A1 (en) | 2010-07-15 | 2012-01-18 | ECP Entwicklungsgesellschaft mbH | Rotor for a pump, produced with an initial elastic material |
US9357991B2 (en) | 2011-11-03 | 2016-06-07 | Biomet Sports Medicine, Llc | Method and apparatus for stitching tendons |
US9381013B2 (en) | 2011-11-10 | 2016-07-05 | Biomet Sports Medicine, Llc | Method for coupling soft tissue to a bone |
US9314241B2 (en) | 2011-11-10 | 2016-04-19 | Biomet Sports Medicine, Llc | Apparatus for coupling soft tissue to a bone |
EP2606919A1 (en) | 2011-12-22 | 2013-06-26 | ECP Entwicklungsgesellschaft mbH | Sluice device for inserting a catheter |
EP2606920A1 (en) | 2011-12-22 | 2013-06-26 | ECP Entwicklungsgesellschaft mbH | Sluice device for inserting a catheter |
EP2745869A1 (en) | 2012-12-21 | 2014-06-25 | ECP Entwicklungsgesellschaft mbH | Sluice assembly for the introduction of a cord-like body, in particular of a catheter, into a patient |
US9918827B2 (en) | 2013-03-14 | 2018-03-20 | Biomet Sports Medicine, Llc | Scaffold for spring ligament repair |
DE102014115337A1 (en) | 2014-10-21 | 2016-04-21 | Nasib Dlaikan-Campos | Stent for splinting a vein and system for placing a stent |
WO2018226991A1 (en) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US10722631B2 (en) | 2018-02-01 | 2020-07-28 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
JP2022540616A (en) | 2019-07-12 | 2022-09-16 | シファメド・ホールディングス・エルエルシー | Intravascular blood pump and methods of manufacture and use |
US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
WO2021062265A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
KR102340696B1 (en) * | 2020-07-28 | 2021-12-17 | 주식회사 티니코 | Nitinol nano-fiber |
WO2023212267A1 (en) * | 2022-04-29 | 2023-11-02 | Board Of Regents, The University Of Texas System | A dilating and stenting oral or nasopharyngeal airway |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010044647A1 (en) * | 1995-11-07 | 2001-11-22 | Leonard Pinchuk | Modular endoluminal stent-grafts |
US6475234B1 (en) * | 1998-10-26 | 2002-11-05 | Medinol, Ltd. | Balloon expandable covered stents |
US6500203B1 (en) * | 1997-01-23 | 2002-12-31 | Boston Scientific Scimed, Inc. | Process for making stent graft with braided polymeric sleeve |
US6551352B2 (en) * | 2001-05-03 | 2003-04-22 | Bionx Implants, Inc. | Method for attaching axial filaments to a self expanding stent |
US20030153973A1 (en) * | 2002-02-08 | 2003-08-14 | Naroun Soun | Braided modular stent with hourglass-shaped interfaces |
US20040134491A1 (en) * | 2002-12-30 | 2004-07-15 | Quiescence Medical | Apparatus and methods for treating sleep apnea |
US7166120B2 (en) * | 2002-07-12 | 2007-01-23 | Ev3 Inc. | Catheter with occluding cuff |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071407A (en) * | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
DE4240177C2 (en) * | 1992-11-30 | 1997-02-13 | Ruesch Willy Ag | Self-expanding stent for hollow organs |
US5549635A (en) * | 1994-01-24 | 1996-08-27 | Solar, Rita & Gaterud, Ltd. | Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore |
WO1995029646A1 (en) * | 1994-04-29 | 1995-11-09 | Boston Scientific Corporation | Medical prosthetic stent and method of manufacture |
BE1009278A3 (en) * | 1995-04-12 | 1997-01-07 | Corvita Europ | Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as. |
JPH09173469A (en) * | 1995-12-27 | 1997-07-08 | Sumitomo Bakelite Co Ltd | Lumen stent and its manufacture |
IL119693A0 (en) * | 1996-11-26 | 1997-02-18 | Roman Gindis | Intranasal snore preventing device |
CA2424551A1 (en) * | 1997-05-27 | 1998-11-27 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
JP4067966B2 (en) * | 2001-01-16 | 2008-03-26 | コーディス・ニューロバスキュラー・インコーポレイテッド | Removable self-expanding aneurysm cover device |
JP2003019209A (en) * | 2001-07-06 | 2003-01-21 | Atsusato Kitamura | Stent |
IL144213A0 (en) * | 2001-07-09 | 2002-05-23 | Mind Guard Ltd | Implantable filter |
JP2003265621A (en) * | 2002-03-14 | 2003-09-24 | Univ Nihon | Indwelling and collecting type stent for disease in sleep apnea syndrome |
WO2003092765A2 (en) * | 2002-05-02 | 2003-11-13 | Dubrul William R | Upper airway device and method |
DE10240725B4 (en) * | 2002-09-04 | 2005-12-08 | Mahr, Richard, Dipl.-Landw. | Device for preventing snoring and respiratory arrest during sleep (apnea) |
JP4214037B2 (en) * | 2002-11-06 | 2009-01-28 | 株式会社パイオラックスメディカルデバイス | Tubular organ treatment tool |
FR2847155B1 (en) * | 2002-11-20 | 2005-08-05 | Younes Boudjemline | METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY |
JP2006526464A (en) * | 2003-06-05 | 2006-11-24 | フローメディカ,インコーポレイテッド | System and method for performing bilateral intervention or diagnosis in a branched body lumen |
US7309345B2 (en) * | 2003-07-25 | 2007-12-18 | Boston Scientific-Scimed, Inc. | Method and system for delivering an implant utilizing a lumen reducing member |
US7361168B2 (en) * | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
US20050288775A1 (en) * | 2004-06-24 | 2005-12-29 | Scimed Life Systems, Inc. | Metallic fibers reinforced textile prosthesis |
US7100612B2 (en) * | 2004-09-09 | 2006-09-05 | Epic Corporation | Nasopharyngeal airway device and method of use |
US8287583B2 (en) * | 2005-01-10 | 2012-10-16 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
GB0607761D0 (en) * | 2006-04-20 | 2006-05-31 | Site Specific Therapies Ltd | Variable density stent |
US20080053458A1 (en) * | 2006-08-30 | 2008-03-06 | Bertrand De Silva | Nasal Catheter With Internal And External Air Flows |
US20080262597A1 (en) * | 2007-04-17 | 2008-10-23 | Medtronic Vascular, Inc. | Prosthesis Fixation Apparatus and Methods |
WO2009072115A2 (en) * | 2007-12-05 | 2009-06-11 | Svip 7 Llc | Devices and methods for treating sleep disordered breathing |
US8241316B2 (en) * | 2008-04-25 | 2012-08-14 | Paul Oberle | Inflatable nasopharyngeal stent |
EP2408510B1 (en) * | 2009-03-17 | 2015-09-16 | Nasolex | Sleep apnea device with naso-pharyngeal bypass |
WO2011025887A1 (en) * | 2009-08-27 | 2011-03-03 | Boston Scientific Scimed, Inc. | Stent with variable cross section braiding filament and method for making same |
US8833373B2 (en) * | 2010-11-12 | 2014-09-16 | The Johns Hopkins University | Nasally inserted airway opening device for obstructive sleep apnea treatment |
-
2006
- 2006-08-29 DE DE102006040301A patent/DE102006040301A1/en not_active Ceased
- 2006-12-01 EP EP06828592.3A patent/EP1959882B1/en not_active Not-in-force
- 2006-12-01 WO PCT/DE2006/002137 patent/WO2007065408A2/en active Application Filing
- 2006-12-01 JP JP2008543648A patent/JP2009518082A/en active Pending
- 2006-12-01 CA CA2632420A patent/CA2632420C/en active Active
- 2006-12-01 US US12/096,457 patent/US20100319708A1/en not_active Abandoned
-
2012
- 2012-10-01 US US13/632,596 patent/US10492932B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010044647A1 (en) * | 1995-11-07 | 2001-11-22 | Leonard Pinchuk | Modular endoluminal stent-grafts |
US6500203B1 (en) * | 1997-01-23 | 2002-12-31 | Boston Scientific Scimed, Inc. | Process for making stent graft with braided polymeric sleeve |
US6475234B1 (en) * | 1998-10-26 | 2002-11-05 | Medinol, Ltd. | Balloon expandable covered stents |
US6551352B2 (en) * | 2001-05-03 | 2003-04-22 | Bionx Implants, Inc. | Method for attaching axial filaments to a self expanding stent |
US20030153973A1 (en) * | 2002-02-08 | 2003-08-14 | Naroun Soun | Braided modular stent with hourglass-shaped interfaces |
US7166120B2 (en) * | 2002-07-12 | 2007-01-23 | Ev3 Inc. | Catheter with occluding cuff |
US20040134491A1 (en) * | 2002-12-30 | 2004-07-15 | Quiescence Medical | Apparatus and methods for treating sleep apnea |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9211181B2 (en) * | 2004-11-19 | 2015-12-15 | Pulmonx Corporation | Implant loading device and system |
US20210330441A1 (en) * | 2004-11-19 | 2021-10-28 | Pulmonx Corporation | Implant loading device and system |
US20130023919A1 (en) * | 2004-11-19 | 2013-01-24 | Pulmonx, Inc. | Implant loading device and system |
US9872755B2 (en) * | 2004-11-19 | 2018-01-23 | Pulmonx Corporation | Implant loading device and system |
US20160058536A1 (en) * | 2004-11-19 | 2016-03-03 | Pulmonx Corporation | Implant loading device and system |
US11083556B2 (en) * | 2004-11-19 | 2021-08-10 | Pulmonx Corporation | Implant loading device and system |
US11103378B2 (en) | 2008-10-02 | 2021-08-31 | Lumen Devices, LLC | Palate retainer with attached nasopharyngeal airway extender for use in the treatment of obstructive sleep apnea |
US10022262B2 (en) * | 2008-10-02 | 2018-07-17 | Lumen Devices Llc | Palate retainer with attached nasopharyngeal airway extender for use in the treatment of obstructive sleep apnea |
US20110178439A1 (en) * | 2008-10-02 | 2011-07-21 | Irwin John N | A palate retainer with attached nasopharyngeal airway extender for use in the treatment of obstructive sleep apnea |
US11510806B2 (en) | 2008-11-25 | 2022-11-29 | Lumen Devices, Llc. | Devices, systems and methods for the treatment of sleep apnea |
WO2012066464A2 (en) * | 2010-11-15 | 2012-05-24 | Sody Naimer | Oropharyngeal airway support assembly |
WO2012066464A3 (en) * | 2010-11-15 | 2012-07-12 | Sody Naimer | Oropharyngeal airway support assembly |
US11116950B2 (en) | 2011-02-09 | 2021-09-14 | Klaus Duering | Stent for splinting a nasal passage |
US20140018839A1 (en) * | 2011-02-09 | 2014-01-16 | Peter Renner | Stent for splinting a nasal passage |
US11517471B2 (en) | 2011-02-17 | 2022-12-06 | Lumen Devices, Llc. | Apparatus and methods for the treatment of sleep apnea |
US20180104039A1 (en) * | 2011-09-23 | 2018-04-19 | Pulmonx Corporation | Implant loading device and system |
US10350048B2 (en) * | 2011-09-23 | 2019-07-16 | Pulmonx Corporation | Implant loading device and system |
US8998986B1 (en) | 2013-07-05 | 2015-04-07 | Zdzislaw B. Malinowski | Nasal stent |
US10569037B2 (en) | 2014-02-14 | 2020-02-25 | John M. O'Day | Nasopharyngeal device for obstructive sleep apnea syndrome |
US20170071766A1 (en) * | 2014-03-13 | 2017-03-16 | Klaus Düring | Compressible self-expandable stent for splinting and/or keeping open a cavity, an organ duct, and/or a vessel in the human or animal body |
CN106163457A (en) * | 2014-03-13 | 2016-11-23 | 克劳斯·迪林 | Boards wall and/or stay open the compressible from expanding cribbing of the chamber in human body or animal body, organ conduit and/or blood vessel |
US20180055666A1 (en) * | 2015-09-30 | 2018-03-01 | Neurvana Medical, Llc | Treatment Systems Processes and Devices Addressing Cerebral Vasospasm/Vasoconstriction |
WO2020001618A1 (en) * | 2018-06-29 | 2020-01-02 | 小牛科技河北有限公司 | Nasopharynx stent for stopping snoring |
US20210030584A1 (en) * | 2018-06-29 | 2021-02-04 | Xiaoniu Health Co., Ltd. | Nasopharynx stent for anti-snoring |
WO2020001627A1 (en) * | 2018-06-29 | 2020-01-02 | 小牛科技河北有限公司 | Nasopharynx stent for stopping snoring |
US20220401253A1 (en) * | 2021-06-18 | 2022-12-22 | Diego Gonzalez Joven | Device for preventing sleep apnea and snoring |
Also Published As
Publication number | Publication date |
---|---|
EP1959882A2 (en) | 2008-08-27 |
US10492932B2 (en) | 2019-12-03 |
EP1959882B1 (en) | 2014-02-12 |
CA2632420A1 (en) | 2007-06-14 |
WO2007065408A3 (en) | 2007-11-01 |
WO2007065408A8 (en) | 2008-06-19 |
CA2632420C (en) | 2017-10-03 |
JP2009518082A (en) | 2009-05-07 |
WO2007065408A2 (en) | 2007-06-14 |
DE102006040301A1 (en) | 2008-03-06 |
US20130090720A1 (en) | 2013-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10492932B2 (en) | Device for splinting a cavity, organ duct and/or vessel | |
JP5623411B2 (en) | Method and device for treating sleep apnea | |
US20040020492A1 (en) | Upper airway device and method | |
JP4982047B2 (en) | Obstructive sleep apnea syndrome resolver | |
US20210060271A1 (en) | Device for sealing a tracheostoma in a patient | |
EP2734149B1 (en) | Devices and methods for treating sleep disordered breathing | |
KR200405903Y1 (en) | Mask for inhibiting mouth opening during the sleep | |
US9265650B2 (en) | Method of inserting an implant into a cavity in a periosteum region | |
JP2009034384A (en) | Obstructive sleep apnea syndrome dissolving device | |
KR20090022709A (en) | Prosthesis for preventing snoring and the method for preventing snoring | |
WO2007049836A1 (en) | Mask for inhibiting mouth opening during the sleep | |
WO2012066464A2 (en) | Oropharyngeal airway support assembly | |
KR100962688B1 (en) | Palatal implant and tongue implant for the treatment of snoring and sleep apnea | |
BR112015023362B1 (en) | Implant to treat obstructive airway disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DR. KLAUS DURING, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MAHR, RICHARD;REEL/FRAME:023047/0970 Effective date: 20081121 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: DUERING, KLAUS, DR., GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAHR, RICHARD;PFEFFER, JOACHIM GEORG;SIGNING DATES FROM 20081117 TO 20081121;REEL/FRAME:048686/0659 |